Altered mitochondrial regulation in quadriceps muscles of patients with COPD

Clinical Physiology and Functional Imaging

Volumn 31, Issue 2, 2011, Pages 124-131

  Naimi, Ashley I ^a,b   Bourbeau, Jean ^c   Perrault, Helene ^c   Baril, Jacinthe ^c   Wright Paradis, Cynthia ^d   Rossi, Amanda ^d   Taivassalo, Tanja ^c   Sheel, A William ^e   Rabøl, Rasmus ^a   Dela, Flemming ^a   Boushel, Robert ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b IL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d Gina Cody School of Engineering and Computer Science   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Mitochondrial respiration; Skeletal muscle

Indexed keywords

CYTOCHROME C OXIDASE;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; MITOCHONDRION; MUSCLE BIOPSY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RESPIROMETRY; VASTUS LATERALIS MUSCLE;

ADENOSINE DIPHOSPHATE; AGED; BIOPSY; CASE-CONTROL STUDIES; CELL RESPIRATION; DENMARK; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; HUMANS; LUNG; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RESPIRATORY FUNCTION TESTS; SUCCINIC ACID;

EID: 79851490877     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2010.00988.x     Document Type: Article

References (49)

1. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J (2003); 2: 347-360.
2. Aliverti A, Stevenson N, Dellaca RL, Lo Mauro A, Pedotti A, Calverley PMA. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax (2004); 59: 210-216.
3. Allaire J, Maltais F, Doyon JF, Noel M, Leblanc P, Carrier G, Simard C, Jobin J. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax (2004); 59: 673-678.
4. Andersen P, Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol (1985); 366: 233-249.
5. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax (2008); 63: 100-107.
6. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998); 158: 629-634.
7. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia (2007); 50: 790-796.
8. Boushel R, Gnaiger E, Wright-Paradis C, Calbet JAL, Munch-Andersen T, Sondergaard H, Helge JW, Saltin B. Skeletal muscle mitochondrial capacity exceeds in-vivo oxygen delivery in humans. Mitochondrion (in press).
9. Caron MA, Debigare R, Dekhuijzen R, Maltais F. Comparative assessment of the quadriceps and the diaphragm in patients with COPD. J Appl Physiol (2009); 107: 952-961.
10. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, LeBlanc P, Prefault C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003); 167: 1664-1669.
11. Crul T, Testelmans D, Spruit M, Troosters T, Gosselink R, Geeraerts I, Decramer M, Gayan-Ramirez G. Gene expression profiling in vastus lateralis muscle during an acute exacerbation of COPD. Cell Physiol Biochem (2010); 25: 491-500.
12. D'Agostino B, Polverino M, Cirino G, Lombardi F, Orlotti D, Matteis M, Rossi F. Exercise capacity and cytochrome oxidase activity in muscle mitochondrial activity of COPD patients. Respir Med (2010); 104: 83-90.
13. Debigare R, Maltais F, Cote FH, Michaud A, Koechlin C, leBlanc P, Hussain SN. Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD (2008); 5: 75-84.
14. Decramer M, Ferguson G. Clinical saftey of long-acting beta 2-agonist and inhaled corticosteroid combination therapy in COPD. COPD (2006); 3: 163-171.
15. Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996); 153: 1958-1964.
16. Decramer M, De Benedetto F, Del Ponte A, Marini S. Systemic effects of COPD. Respir Med (2005); 99: S3-S10.
17. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J (2001); 17: 939-945.
18. Gosker HR, van Mameren H, van Dijk PJ, Engelen MPKJ, van der Vusse GJ, Wouters EFM, Schols AMWJ. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J (2002); 19: 617-625.
19. Gosker HR, Schrauwen P, Hesselink MKC, Schaart G, van der Vusse GJ, Wouters EFM, Schols AMWJ. Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J (2003); 22: 88-93.
20. Gosker HR, Hesselink MKC, Duimel H, Ward KA, Schols AMW. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Am J Respir Crit Care Med (2007); 30: 73-79.
21. Guerrero K, Wuyam B, Mezin P, Vivodtzev I, Vendelin M, Borel JC, Hacini R, Chavanon O, Imbeaud S, Saks V, C P. Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant muscle. Am J Physiol (2005); 289: R1144-R1154.
22. Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI. Acute effect of oral steroids on muscle function in chronic obstructive puæmomnary disease. Eur Respir J (2004); 24: 137-142.
23. Hutter E, Skovbro M, Lener B, Prats C, Rabøl R, Dela F. Oxidative stress and mitochondrial impairment can be separated from lipofuscin accumulation in aged human skeletal muscle. Aging Cell (2007); 6: 245-256.
24. Jagoe RT, Engelen MPKJ. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J (2003); 22(suppl): 52S-63.
25. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1995); 15: 374-377.
26. Killian K, Leblanc P, Martin D, Summers E, Jones N, Campbell E. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis (1992); 146: 935-940.
27. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, Prefaut C. Hypoxemia enhances peripheral muscle oxidative stress in chronic onstructive pulmonary disease. Thorax (2007); 60: 834-841.
28. Maltais F, Simard A, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med (1996); 153: 288-293.
29. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Belanger M, Breton M-J, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax (2000); 55: 848-853.
30. Man WDC, Pemp P, Moxham J, Polkey MI. Skeletal muscle dysfunction in COPD: clinical and laboratory observations. Clin Sci (2009); 117: 251-264.
31. O'Donnell DE, Revill SM, Webb KA. Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2001); 164: 770-777.
32. Picard M, Godin R, Sinnreich M, Baril J, Bourbeau J, Perrault H, Taivassalo T, Burelle Y. The mitochondrial phenotype of peripheral muscle in COPD: disuse or dysfunction? Am J Respir Crit Care Med (2008); 178: 1040-1047.
33. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Torres A, Lazarao A, Ferreira A, Agusti A. Abnormal transition pore kinetics and cytochrome c release in muscle mitochondria of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2009a); 40: 746-750.
34. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Gonzalez-Aragoneses F, Bravo J-L, Villar-Alvarez F, Camano S. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J (2009b); 33: 1045-1052.
35. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007); 176: 532-555.
36. Rabinovich RA, Bastos R, Ardite E, Llinas L, Orozco-Levi M, Gea J, Vilaro J, Barbera JA, Rodriguez-Roisin R, Fernandez-Checa JC, Roca J. Mitochondrial dysfunction in COPD patients with low body mass index. Eur Respir J (2007); 29: 643-650.
37. Rabøl R, Højberg PM, Almdal T, Boushel R, Haugaard SB, Madsbad S, Dela F. Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes. Diabetes Obes Metab (2009); 11: 355-360.
38. Radom -Aizik S, Kaminski N, Hayek S, Halkan H, Cooper DM, Ben-Dov I. Effects of exercise training on muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol (2007); 102: 1976-1984.
39. Rasmussen U, Krustrup P, Kjær M, Rasmussen HN. Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria. Exp Gerontol (2003); 38: 877-886.
40. Remels AH, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR, Schols AM. Persoxisome proliferator-qctivated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J (2007); 30: 245-252.
41. Rud A, Christensen CC, Ryg M, Edvarsen A, Skumlien S, Hallen J. Higher skeletal muscular metabolic reserve capacity in COPD patients than healthy subjects. Scand J Med Sci Sports (2008); 1600: 838-846.
42. Russell APP, Somm E, Debigare RMD, Hartley OP, Richard DP, Gastaldi GMD, Melotti A, Michaud A, Giacobino J-PPMD, Muzzin PP, LeBlanc PMD, Maltais FMD. COPD Results in a Reduction in UCP3 Long mRNA and UCP3 Protein Content in Types I and IIa Skeletal Muscle Fibers. J Cardiopulm Rehabil (2004); 24: 332-339.
43. Sato Y, Asoh T, Y H, Fujimatsu Y, Higuchi I, Oizumi K. Morphologic and histochemical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur J Neurol (1997); 37: 116-121.
44. Sauleda J, Garcia-Palmer F, Wiesner Rudolf J, Tarraga S, Harting I, Tomas P, Gomez C, Saus C, Palou A, Agusti Alvar GN. Cytochrome Oxidase Activity and Mitochondrial Gene Expression in Skeletal Muscle of Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (1998); 157: 1413-1417.
45. Sergi G, Coin A, Marin S, Vianello A, Manzan A, Peruzza A, Inelmen EM, Busetto L, Mulone S, Enzi G. Body composition and resting energy expenditure in elderly patients with chronic obstructive pulmonary disease. Respir Med (2006); 100: 1918-1924.
46. Troosters T, Probst VS, Crul T, Pitta F, Gayan-Ramirez G, Decramer M, Gosselink R. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010a); 181: 1072-1077.
47. Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, Benzo R, Andre D, Weisman I, Decramer M. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med (2010b); 104: 1005-1011.
48. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta (1987); 892: 191-196.
49. Whittom F, Jobin J, Simard P-M, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc (1998); 30: 1467-1474.